Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone

被引:127
作者
de Castro, F
Ruiz, R
Montoro, L
Pérez-Hernández, D
Padilla, ESC
Real, LM
Ruiz, A
机构
[1] Neocodex, Dept Genom Estructural, Seville 41020, Spain
[2] Allat Med, Madrid, Spain
[3] Hosp Univ Principe Asturias, Alcala De Henares, Spain
关键词
controlled ovarian stimulation; recombinant FSH; FSH receptor; Ser680Asn; pharmacogenetics; FRET; real-time PCR;
D O I
10.1016/S0015-0282(03)00795-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the association between FSH efficacy and FSHR alleles. Design: Retrospective study. Setting: University-based fertility unit and a private center for biomedical research. Patient(s): One hundred two women with ovarian function who were undergoing controlled ovarian stimulation (COS). Women were categorized as poor responders (less than or equal to3 ovarian follicles at the end of the cycle) or normal responders (>3 follicles). Intervention(s): Daily administration of exogenous FSH. Main Outcome Measure(s): Number of good or poor responders. Result(s): The allele frequency and genotype distribution of the Ser680Asn marker differed significantly between groups. Cycle cancellations were increased (21%) among women who were homozygous for Ser680 compared with Ser/Asn and Asn/Asn patients, and 36% of poor-responders were homozygous for Ser680. Conclusion(s): The results support a role for FSHR gene in COS outcome. However, the weight of this factor is probably low. The Ser680 allele may act in concert with other environmental and genetic factors that contribute to FSH efficacy. (C) 2003 by American Society for Reproductive Medicine.
引用
收藏
页码:571 / 576
页数:6
相关论文
共 27 条
[11]   The frequency of an inactivating point mutation (566C→T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry [J].
Jiang, N ;
Aittomäki, K ;
Nilsson, C ;
Pakarinen, P ;
Iitiä, A ;
Torresani, T ;
Simonsen, K ;
Goh, V ;
Pettersson, K ;
de la Chapelle, A ;
Huhtaniemi, I .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (12) :4338-4343
[12]   Differentiating clinical profiles: predicting good responders, poor responders, and hyperresponders [J].
Kligman, I ;
Rosenwaks, Z .
FERTILITY AND STERILITY, 2001, 76 (06) :1185-1190
[13]  
LOPATA A, 1980, FERTIL STERIL, V33, P117
[14]   Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype [J].
Mayorga, MP ;
Gromoll, J ;
Behre, HM ;
Gassner, C ;
Nieschlag, E ;
Simoni, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09) :3365-3369
[15]   Mutation in bone morphogenetic protein receptor-IB is associated with increased ovulation rate in Booroola Merino ewes [J].
Mulsant, P ;
Lecerf, F ;
Fabre, S ;
Schibler, L ;
Monget, P ;
Lanneluc, I ;
Pisselet, C ;
Riquet, J ;
Monniaux, D ;
Callebaut, I ;
Cribiu, E ;
Thimonier, J ;
Teyssier, J ;
Bodin, L ;
Cognié, Y ;
Chitour, N ;
Elsen, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (09) :5104-5109
[16]   A SNPshot: pharmacogenetics and the future of drug therapy [J].
Pfost, DR ;
Boyce-Jacino, MT ;
Grant, DM .
TRENDS IN BIOTECHNOLOGY, 2000, 18 (08) :334-338
[17]   Pharmacogenetics and the practice of medicine [J].
Roses, AD .
NATURE, 2000, 405 (6788) :857-865
[18]  
Ruiz A, 2001, CLIN CHEM, V47, P1939
[19]   New concepts in superovulation strategies for assisted conception treatments [J].
Salha, O ;
Balen, AH .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2000, 12 (03) :201-206
[20]   Genetic control of hormone-induced ovulation rate in mice [J].
Spearow, JL ;
Barkley, M .
BIOLOGY OF REPRODUCTION, 1999, 61 (04) :851-856